Amble vs Roen Rx
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Amble
Best for mainstream telehealth GLP-1 accessStarting at $179/mo
Roen Rx
Best for patients with insurance seeking brand-name GLP-1 access with compounded fallbackStarting at $25/mo
Side-by-Side Comparison
| Feature | Amble | Roen Rx |
|---|---|---|
| Overall Score | ✓7.4/10 | 7.0/10 |
| Starting Price | $179/mo | ✓$25/mo |
| Editorial Rating | ✓3.7 ★ /5 | 3.5 ★ /5 |
| Features | 3 features | ✓7 features |
| States Available | ✓50 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Amble
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Roen Rx
Pros
- ✓Insurance coordination for brand-name GLP-1s — as low as $25/mo
- ✓Both compounded and brand-name options
- ✓LegitScript approved with Compounded USA badge
- ✓Compounded semaglutide from $151/mo quarterly
- ✓Also offers primary care, mental health, and other specialties
Cons
- ✗State availability not publicly disclosed
- ✗Insurance coordination may not work for all plans
- ✗Broader platform (ED, hair loss, skincare, birth control)
Our Verdict
Amble edges out Roen Rx with a higher overall score of 7.4/10 and is particularly strong for mainstream telehealth GLP-1 access. Roen Rx remains a solid alternative, especially if you're looking for patients with insurance seeking brand-name GLP-1 access with compounded fallback.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.